Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Taddei, S., Virdis, A., Ghiadoni, L., et al. Endothelium, aging, and hypertension. Curr. Hypertens. Rep. 2006; 8(1):84–89.
Nathan, C., Xie, Q.W. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 1994; 269:13725–13728.
Moncada, S., Palmer, R.M., Higgs, E.A. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991; 43(2):109–142.
Matz, R.L., Andriantsitohaina, R. Age-related endothelial dysfunction potential implications for pharmacotherapy. Drugs Aging 2003; 20(7):527–550.
Shi, Y., Ku, D.D., Man, R.Y., et al. Augmented EDHF-mediated relaxations attenuate endothelial dysfunction in femoral and mesenteric, but not in carotid arteries from type I diabetic rats. J. Pharmacol. Exp. Ther. 2006; 318(1):276–281.
Onguru, O., Casey, M.B., Kajita, S., et al. Cyclooxigenase-2 and thromboxane synthase in non-endocrine and endocrine tumors: A review. Endocr. Pathol. 2005; 16(4):253–278.
Madamanchi, N.R., Vendrov, A., Runge, M.S. Oxidative stress and vascular disease. Arterioscler. Thromb. Vasc. Biol. 2005; 25:29–38.
Langleben, D., Dupuis, J., Langleben, I., et al. Etiology-specific endothelin-1 clearance in human precapillary pulmonary hypertension. Chest 2006; 129(3):689–695.
Baudin, B. New aspects on angiotensin-converting enzyme: From gene to disease. Clin. Chem. Lab. Med. 2002; 40(3):256–265.
Forstermann, U., Munzel, T. Endothelial nitric oxide synthase in vascular disease: From marvel to menace. Circulation 2006; 113(13):1708–1714.
Deanfield, J., Donald, A., Ferri, C., et al. Part I: Methodological issues for assessment in the different vascular beds: A statement by the Working Group on endothelin and endothelial factors of the European Society of Hypertension. J. Hypertens. 2005; 23:7–17.
Chung, H.Y., Kim, H.J., Kim, K.W., et al. Molecular inflammation hypothesis of aging based on the anti-aging mechanism of calorie restriction. Microsc. Res. Tech. 2002; 59:264–272.
Harrison, D., Griendling, K.K., Landmesser, U., et al. Role of oxidative stress in atherosclerosis. Am. J. Cardiol. 2003; 91:7A–11A.
Ferroni, P., Basili, S., Paoletti, V., et al. Endothelial dysfunction and oxidative stress in arterial hypertension. Nutr. Metab. Cardiovasc. Dis. 2006; 16(3):222–233.
Berry, C.E., Hare, J.M. Xanthine oxidoreductase and cardiovascular disease: Molecular mechanisms and pathophysiological implications. J. Physiol. 2004; 555(Pt 3):589–606.
Douette, P., Sluse, F.E. Mitochondrial uncoupling proteins: New insights from functional and proteomic studies. Free Rad. Biol. Med. 2006; 40(7):1097–1107.
Esch, T., Stefano, G. Proinflammation: A common denominator or initiator of different pathophysiological disease processes. Med. Sci. Monit. 2002; 8:HY1–HY9.
Alessio, P. Aging and the endothelium. Exp. Gerontol. 2004; 39:165–171.
Esmon, C.T. The interactions between inflammation and coaguation. Br. J. Haematol. 2005; 131(4):417–430.
Pasceri, V., Willerson, J.T., Yeh, E.T.H. Direct proinflammatory effect of C-reactive protein in human endothelial cells. Circulation 2000; 102:2165–2168.
Schiffrin, E.L. Role of endothelin-1 in hypertension and vascular disease. Am. J. Hypertens. 2001; 14:S83–S89.
Taddei, S., Virdis, A., Ghiadoni, L., et al. Vasoconstriction to endogenous endothelin-1 is increased in the peripheral circulation of patients with essential hypertension. Circulation 1999; 100:1680–1683.
Haynes, W.G., Webb, D.J. Endothelin as a regulator of cardiovascular function in health and disease. J. Hypertens. 1998; 16:1081–1098.
Bohm, F., Settergren, M., Pernow, J. Vitamin C blocks vascular dysfunction and release of interleukin-6 induced by endothelin-1 in humans in vivo. Atherosclerosis 2006 Mar 7; [Epub ahead of print].
Cheng, Z.J., Vapaatalo, H., Mervaala, E. Angiotensin II and vascular inflammation. Med. Sci. Monit. 2005; 1186:RA194–205.
Imanishi, T., Hano, T., Nishio, I. Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. J. Hypertens. 2005; 23:97–104.
Najjar, S.S., Scureti, A., Lakatta, E.G. Arterial aging, is it an immutable cardiovascular risk factor? Hypertension 2005; 46:454–462.
Kim, S.F., Huri, D.A., Snyder, S.H. Inducible nitric oxide synthase binds S-nitrosylates, and activates cyclooxygenase-2. Science 2005; 310(5756):1966–1970.
Van der Loo, B., Labugger, R., Skepper, J., et al. Enhanced peroxynitrite formation is associated with vascular aging. J. Exp. Med. 2000; 192(12):1731–1743.
Taddei, S., Virdis, A., Ghiadoni, L. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension 1997; 29(2):274–279.
Boger, R., Schwedhelm, E., Maas, R., et al. ADMA and oxidative stress may relate to the progression of renal disease: Rationale design of the VIVALDI study. Vasc. Med. 2005; 10:S97–102.
Singh, N., Prasad, S., Singer, D., MacAllister, R. Ageing is associated with impairment of nitric oxide and prostanoid dilator pathways in the human forearm. Clin. Sci. 2002; 102:595–600.
Massimo, C., Scarpelli, P., Di Lorenzo, N., et al. Impaired plasma nitric oxide availability and extracellular superoxide dismutase activity in healthy humans with advancing age. Life Sci. 2006; 78:1163–1167.
Eskurza, I., Myerburgh, L.A., Kahn, Z.D. Tetrahydrobiopterin augments endothelium-dependent dilatation in sedentary but not in habitually exercising older adults. J. Physiol. 2005; 568(3):1057–1065.
Bachschmid, M., Van der Loo, B., Schüler, K., et al. Oxidative stress-associated vascular aging is independent of the protein kinase C/NAD(P)H oxidase pathway. Arch. Gerontol. Geriatr. 2004; 38:181–190.
Hamilton, C.A., Brosnan, M.L., Mclntyre, M., Graham, D., Dominiczak, A.F. Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension. 2001 Feb; 37:529–34.
Gössl, M., Lerman, A. Endothelin: Beyond a vasoconstrictor. Circulation 2006; 113:1156–1158.
Urakami-Harasawa, L., Shimokawa, H., Nakashima, M., et al. Importance of endothelium-derived hyperpolarizing factor in human arteries. J. Clin. Invest. 2006; 100(11):2793–2799.
Vasa, M., Breitschopf, Z.A.. Nitric oxide activates telomerase and delays endothelial cell senescence. Circ. Res. 2000; 87(7):540–542.
Brandes, R., Fleming, I., Busse, R. Endothelial aging. Cardiovas. Res. 2005; 66:286–294; J. Physiol. 2005; 568(3):1057–1065.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Rodríguez-Mañas, L., De La Fuente, M.E., Rodríguez, M.C. (2008). Endothelial Function in the Healthy Aged. In: MachasNúñez, J.F., Cameron, J.S., Oreopoulos, D.G. (eds) The Aging Kidney in Health and Disease. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-72659-5_7
Download citation
DOI: https://doi.org/10.1007/978-0-387-72659-5_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-72658-8
Online ISBN: 978-0-387-72659-5
eBook Packages: MedicineMedicine (R0)